BeOne Medicines (ONC) Times Interest Earned (2015 - 2026)
BeOne Medicines' (ONC) quarterly Times Interest Earned came in at $7.6 in Q1 2026, up 787.12% year-on-year from $0.86 in Q1 2025, and down 49.52% on a QoQ basis from $15.05 in Q4 2025.
BeOne Medicines (ONC) Times Interest Earned (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has 12 years of Times Interest Earned data on file, last reported at $7.6 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 787.12% year-over-year to $7.6 in Q1 2026; TTM through Mar 2026 was $9.82, a 287.74% increase from a year earlier, with the FY2025 full-year figure at $0.12, up 173.42% from the prior year.
- Times Interest Earned for Q1 2026 stood at $7.6, down from $15.05 in the prior quarter.
- Over the last five years, Times Interest Earned for ONC reached as high as $32.72 in Q4 2023 and fell as low as -$80.54 in Q2 2022.
- Historically, Times Interest Earned has averaged -$23.07 across 5 years, with a median of -$8.4 in 2024.
- Across the five-year window, Times Interest Earned tumbled 763.55% in 2022 and soared 787.12% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$40.81 in 2022, then soared by 180.17% to $32.72 in 2023, then plunged by 115.12% to -$4.95 in 2024, then surged by 404.33% to $15.05 in 2025, then slumped by 49.52% to $7.6 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were $7.6 in Q1 2026, $15.05 in Q4 2025, and $12.89 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.60 |
| Dec 31, 2025 | 15.05 |
| Sep 30, 2025 | 12.89 |
| Jun 30, 2025 | 7.29 |
| Mar 31, 2025 | 0.86 |
| Dec 31, 2024 | -4.95 |
| Sep 30, 2024 | -8.40 |
| Jun 30, 2024 | -8.10 |
| Mar 31, 2024 | -21.07 |
| Dec 31, 2023 | 32.72 |
| Sep 30, 2023 | -20.21 |
| Jun 30, 2023 | -65.16 |
| Mar 31, 2023 | -74.00 |
| Dec 31, 2022 | -40.81 |
| Sep 30, 2022 | -78.33 |
| Jun 30, 2022 | -80.54 |
| Mar 31, 2022 | -66.99 |
| Dec 31, 2021 | 29.01 |
| Sep 30, 2021 | -60.76 |
| Jun 30, 2021 | -62.26 |